Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,399 | -27,851 | -58,289 | -39,291 | -13,831 |
| Depreciation Amortization | 24,479 | 21,969 | 21,982 | 10,279 | 4,037 |
| Accounts receivable | 5,186 | 6,525 | 1,544 | 1,764 | -1,973 |
| Other Working Capital | -1,150 | 211 | 1,681 | -3,429 | -5,661 |
| Other Operating Activity | -1,729 | -4,645 | 7,118 | 10,990 | 6,521 |
| Operating Cash Flow | $-12,613 | $-3,791 | $-25,964 | $-19,687 | $-10,907 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -2,341 | N/A | N/A |
| Net Acquisitions | N/A | N/A | 202 | 323 | N/A |
| Other Investing Activity | -3,137 | -86 | -643 | -679 | -39 |
| Investing Cash Flow | $-3,137 | $-86 | $-2,782 | $-356 | $-39 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 42,212 | 51,206 | N/A | N/A |
| Debt Repayment | -2,746 | -2,330 | -7,056 | -3,352 | -3,059 |
| Common Stock Issued | 4,825 | 307 | 40,148 | 32,250 | 32,250 |
| Other Financing Activity | -953 | -45,653 | -53,984 | -10,398 | -4,293 |
| Financing Cash Flow | $1,126 | $-5,464 | $30,314 | $18,500 | $24,898 |
| Beginning Cash Position | 49,901 | 49,901 | 48,333 | 48,333 | 48,333 |
| End Cash Position | 35,277 | 40,560 | 49,901 | 46,790 | 62,285 |
| Net Cash Flow | $-14,624 | $-9,341 | $1,568 | $-1,543 | $13,952 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,613 | -3,791 | -25,964 | -19,687 | -10,907 |
| Capital Expenditure | N/A | N/A | -2,341 | N/A | N/A |
| Free Cash Flow | -12,613 | -3,791 | -28,305 | -19,687 | -10,907 |